title: Mortality in sickle cell disease. Life expectancy and risk factors for early death.
abstract: BACKGROUND
  Information on life expectancy and risk factors for early death among patients with sickle cell disease (sickle cell anemia, sickle cell-hemoglobin C disease, and the sickle cell-beta-thalassemias) is needed to counsel patients, target therapy, and design clinical trials.
  
  
  METHODS
  We followed 3764 patients who ranged from birth to 66 years of age at enrollment to determine the life expectancy and calculate the median age at death. In addition, we investigated the circumstances of death for all 209 adult patients who died during the study, and used proportional-hazards regression analysis to identify risk factors for early death among 964 adults with sickle cell anemia who were followed for at least two years.
  
  
  RESULTS
  Among children and adults with sickle cell anemia (homozygous for sickle hemoglobin), the median age at death was 42 years for males and 48 years for females. Among those with sickle cell-hemoglobin C disease, the median age at death was 60 years for males and 68 years for females. Among adults with sickle cell disease, 18 percent of the deaths occurred in patients with overt organ failure, predominantly renal. Thirty-three percent were clinically free of organ failure but died during an acute sickle crisis (78 percent had pain, the chest syndrome, or both; 22 percent had stroke). Modeling revealed that in patients with sickle cell anemia, the acute chest syndrome, renal failure, seizures, a base-line white-cell count above 15,000 cells per cubic millimeter, and a low level of fetal hemoglobin were associated with an increased risk of early death.
  
  
  CONCLUSIONS
  Fifty percent of patients with sickle cell anemia survived beyond the fifth decade. A large proportion of those who died had no overt chronic organ failure but died during an acute episode of pain, chest syndrome, or stroke. Early mortality was highest among patients whose disease was symptomatic. A high level of fetal hemoglobin predicted improved survival and is probably a reliable childhood forecaster of adult life expectancy.
authors.affiliation: Department of Medicine, Children's Hospital, Boston, MA 02115.
authors.forename: O S
authors.initials: OS
authors.lastname: Platt
authors.forename: D J
authors.initials: DJ
authors.lastname: Brambilla
authors.forename: W F
authors.initials: WF
authors.lastname: Rosse
authors.forename: P F
authors.initials: PF
authors.lastname: Milner
authors.forename: O
authors.initials: O
authors.lastname: Castro
authors.forename: M H
authors.initials: MH
authors.lastname: Steinberg
authors.forename: P P
authors.initials: PP
authors.lastname: Klug
mesh_terms: D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000401:mortality*; D002423:Cause of Death; D002648:Child; D005260:Female; D006450:Hemoglobin SC Disease / Q000401:mortality*; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D011336:Probability; D012044:Regression Analysis; D012307:Risk Factors; D016019:Survival Analysis; D017086:beta-Thalassemia / Q000401:mortality